Search

Search bills, members, committees and pages...

HB 598

Utah HouseFailed

Summary

HB 598, “Uterine Fibroid Amendments”, was introduced in the House on Feb 24, 2026 by Rep. Rosalba Dominguez (D). It last saw action on Mar 6, 2026: House/ filed in House file for bills not passed.


Record

Text

HB 598 has no co-sponsors and has not gone to a roll call.

hb598/introduced.txt
02-24 14:14 H.B. 598
Uterine Fibroid Amendments
2026 GENERAL SESSION
STATE OF UTAH
Chief Sponsor: Rosalba Dominguez
Senate Sponsor:
LONG TITLE
General Description:
This bill addresses uterine fibroid research and education.
Highlighted Provisions:
This bill:
▸ requires the Department of Health and Human Services (department) to coordinate
research and education related to uterine fibroids;
▸ permits the department to coordinate with medical research organizations to carry out the
department's research and education coordination efforts, including data sharing;
▸ requires the department to report to the Health and Human Services Interim Committee;
▸ provides a repeal date for research and education efforts, and related reporting
requirements;
▸ makes technical and conforming changes; and
▸ defines terms.
Money Appropriated in this Bill:
None
Other Special Clauses:
None
Utah Code Sections Affected:
AMENDS:
63I-2-226, as last amended by Laws of Utah 2025, Chapters 277, 414
H.B. 598
ENACTS:
26B-7-126, Utah Code Annotated 1953
Be it enacted by the Legislature of the state of Utah:
Section 1. Section 26B-7-126 is enacted to read:
26B-7-126 . Uterine fibroid research and education.
(1) As used in this section:
H.B. 598 02-24 14:14
(a) "Health care provider" means the same as that term is defined in Section 78B-3-403.
(b) "Medical research organization" means an institution of higher education, a research
organization, or a healthcare facility that conducts medical research:
(i) that is approved by an institutional review board; and
(ii) in accordance with applicable ethics requirements for human subject research.
(c)(i) "Uterine fibroid" means a non-cancerous growth in or on the uterus.
(ii) "Uterine fibroid" includes a leiomyoma or a myoma.
(2) The department shall coordinate efforts related to research of and education about
uterine fibroids.
(3) The department's coordination efforts shall encourage:
(a) research on:
(i) how frequently individuals in the state are diagnosed with uterine fibroids;
(ii) the ages at which individuals are diagnosed with, and treated for, uterine fibroids;
(iii) health care services delivered to individuals in the state diagnosed with uterine
fibroids;
(iv) how many hysterectomies are performed:
(A) as a treatment for uterine fibroids; or
(B) for which uterine fibroids are a factor in performing the hysterectomy;
(v) the availability of non-hysterectomy treatment options for individuals in the state
diagnosed with uterine fibroids, including drugs and devices; and
(vi) the impacts of uterine fibroids on reproductive health, including as a barrier to
reproduction; and
(b) data collection and data sharing related to the subjects described in Subsection (3)(a).
(4) The department's coordination efforts shall include education for health care providers
and patients about uterine fibroids to ensure individuals with symptomatic uterine
fibroids receive appropriate treatment, including education about:
(a) the availability and appropriateness of non-hysterectomy treatment options; and
(b) the impacts of uterine fibroids on reproductive health, including as a barrier to
reproduction.
(5) In fulfilling the department's duties described in Subsections (2) through (4), the
department may coordinate with medical research organizations in the state.
(6) In accordance with Chapter 8, Part 5, Utah Health Data Authority, and other applicable
laws, the department may enter into an agreement with medical research organizations
in the state to share identifiable health data for the purpose of fulfilling the requirements
-2-
02-24 14:14 H.B. 598
of Subsection (3).
(7) On or before November 1, 2028, and on or before November 1, 2029, the department
shall report to the Health and Human Services Interim Committee on:
(a) the department's coordination efforts related to research as described in Subsection
(3)(a);
(b) any findings related to the research topics described in Subsection (3)(a), including,
in 2029, a comparison to any findings reported in 2028;
(c) the department's coordination efforts related to education for health care providers
and patients about uterine fibroids;
(d) the department's recommendations, including policy and legislative
recommendations; and
(e) any other data or information the committee requests related to uterine fibroid
research and education.
Section 2. Section 63I-2-226 is amended to read:
63I-2-226 . Repeal dates: Titles 26 through 26B.
(1) Section 26B-1-420, Cannabis Research Review Board, is repealed July 1, 2025.
(2) Subsection 26B-1-421(9)(a), regarding a report to the Cannabis Research Review
Board, is repealed July 1, 2025.
(3) Section 26B-1-423, Rural Physician Loan Repayment Program Advisory Committee --
Membership -- Compensation -- Duties, is repealed July 1, 2026.
(4) Section 26B-2-243, Data collection and reporting requirements concerning incidents of
abuse, neglect, or exploitation, is repealed July 1, 2027.
(5) Subsection 26B-3-215(5), regarding reporting on coverage for in vitro fertilization and
genetic testing, is repealed July 1, 2030.
(6) Subsection 26B-4-201(5), regarding the Cannabis Research Review Board, is repealed
July 1, 2025.
(7) Subsection 26B-4-212(1)(b), regarding the Cannabis Research Review Board, is
repealed July 1, 2025.
(8) Section 26B-4-702, Creation of Utah Health Care Workforce Financial Assistance
Program, is repealed July 1, 2027.
(9) Subsection 26B-4-703(3)(b), regarding per diem and expenses for the Rural Physician
Loan Repayment Program Advisory Committee, is repealed July 1, 2026.
(10) Subsection 26B-4-703(3)(c), regarding expenses for the Rural Physician Loan
Repayment Program, is repealed July 1, 2026.
-3-
H.B. 598 02-24 14:14
(11) Subsection 26B-4-703(6)(b), regarding recommendations from the Rural Physician
Loan Repayment Program Advisory Committee, is repealed July 1, 2026.
(12) Section 26B-5-117, Early childhood mental health support grant program, is repealed
January 2, 2025.
(13) Section 26B-5-302.5, Study concerning civil commitment and the Utah State Hospital,
is repealed July 1, 2025.
(14) Section 26B-6-414, Respite care services, is repealed July 1, 2025.
(15) Section 26B-7-120, Invisible condition alert program education and outreach, is
repealed July 1, 2025.
(16) Section 26B-7-126, Uterine fibroid research and education, is repealed July 1, 2030.
Section 3. Effective Date.
This bill takes effect on May 6, 2026.
-4-

Uterine Fibroid Amendments

Sponsors

Rep. Rosalba Dominguez (D) sponsors HB 598 alone.

Committees

HB 598 went before 1 committee: Rules.

Rules
Rules
Referred to · Feb 24, 2026

History

HB 598 has taken 11 actions since Feb 24, 2026, the latest on Mar 6, 2026.

ChamberAction
Mar 6, 2026
House
House/ strike enacting clause in Clerk of the House
Mar 6, 2026
House
House/ filed in House file for bills not passed
Feb 26, 2026
LFA/ fiscal note sent to sponsor for HB0598 in Version Sponsor
Feb 26, 2026
LFA/ fiscal note publicly available for HB0598 in Released
Feb 26, 2026
House
House/ received fiscal note from Fiscal Analyst in House Rules Committee

Votes

HB 598 has not gone to a roll call.


Source: le.utah.gov · legiscan.com